Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Giselle Saulnier Sholler, MD
Penn State Health Children's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama/children'S of Alabama
Birmingham, Alabama, United States
Elizabeth AlvaRecruiting - Arkansas Children'S Hospital
Little Rock, Arkansas, United States
Kevin BielamowiczRecruiting - Connecticut Children'S Hospital
Hartford, Connecticut, United States
Michael IsakoffRecruiting - Nicklaus Children'S Hospital
Miami, Florida, United States
Guillermo De AnguloRecruiting - Arnold Palmer Hospital for Children
Orlando, Florida, United States
Jamie Libes-BanderRecruiting - St. Joseph'S Children'S Hospital
Tampa, Florida, United States
Don EslinRecruiting - Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
Kelley HutchinsRecruiting - Children'S Mercy Hospitals and Clinics
Kansas City, Kansas, United States
Kevin GinnRecruiting - Cardinal Glennon Children'S Medical Center
St Louis, Missouri, United States
William FergusonRecruiting - Penn State Milton S. Hershey Medical Center and Children'S Hospital
Hershey, Pennsylvania, United States
Valerie BrownRecruiting - Monroe Carrell Jr. Children'S Hospital at Vanderbilt
Nashville, Tennessee, United States
Daniel BenedettiRecruiting - Children'S Medical Center
Dallas, Texas, United States
Tanya WattRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 May 2026
- Primary completion
- 31 May 2033
- Completion
- 31 May 2035
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 289
- Registry id
- NCT06465199
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.